ACCORD UK — Montelukast Importer Profile
Pharmaceutical Importer · #14 buyer for Montelukast · $1.1M import value · 45 shipments · UNITED KINGDOM · DGFT Verified
ACCORD UK is the #14 importer of Montelukast from India with $1.1M in import value and 45 verified shipments. ACCORD UK holds a 0.8% market share in Montelukast imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 13 formulations shipped to 1 country. Overall, ACCORD UK imports 11 pharmaceutical products worth $7.7M across 5 therapeutic categories.
ACCORD UK — Montelukast Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Montelukast to ACCORD UK?
Verified from 45 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | $1.1M | 45 | 100.0% |
ACCORD UK sources Montelukast from 1 verified Indian supplier based on 45 customs records. The primary supplier is INTAS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does ACCORD UK Compare to Nearest Montelukast Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | XXMBEXXPHAXXACEXXICAXX IXX | UNITED STATES | $1.9M | 39 | $50.0K |
| 13 | UNICHEM PHARMACEUTICALS (USA) INC | UNITED STATES | $1.4M | 29 | $50.0K |
| 14 | ACCORD UK ★ | UNITED KINGDOM | $1.3M | 45 | $28.8K |
| 15 | GLENMARK PHARMACEUTICALS EUROPE LTD | UNITED KINGDOM | $1.2M | 70 | $17.7K |
| 17 | ORION CORPORATION | FINLAND | $966.3K | 45 | $21.5K |
ACCORD UK ranks #14 among 1,324 Montelukast importers from India. Average shipment value of $28.8K compared to the market average of $23.1K. The closest competitors by value are XXMBEXXPHAXXACEXXICAXX IXX and UNICHEM PHARMACEUTICALS (USA) INC.
Where Does ACCORD UK Import Montelukast To?
Destination countries from 45 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.1M | 45 | 100.0% |
ACCORD UK imports Montelukast to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $1.1M.
What Montelukast Formulations Does ACCORD UK Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMA DRUGS & MEDI MONTELUKAST 10MG 2X1 | $353.6K | 9 |
| PHARMA DRUGS & MEDI MONTELUKAST 10MG 2X14T(ACCORD-UK AS PER INVOICE | $215.6K | 10 |
| PHARMA DRUG&MED:MONTELUKAST 10MG 2X14T(A | $141.9K | 3 |
| PHARMA DRUGS & MEDI MONTELUKAST 10MG 2X14T(ACCORD-UK AS PER INVOICETBS | $101.8K | 10 |
| PHARMA DRUG&MED:MONTELUKAST 10MG 2X14TA | $100.0K | 2 |
| PHARMA DRUG MED MONTELUKAST 10MG 2X14T ACCORD UK Each film coa tab cont Montelukast Sodium Ph Eur eq to Montelukast 10mg | $50.0K | 1 |
| PHARMA DRUG MED MONTELUKAST 10MG 2X14T ACCORD UK Each film coa tab cont Monte Sodium Ph Eur eq to Mont 10mg Mon ASPERINV | $50.0K | 1 |
| PHARM DRUG&MED:MONTELUKAST 10MG 2X14T(ACCORD-UK)EACH FILM COATED TABLET CONT:MONTELUKAST SODIUM PH.EUR. EQ. TO MONTELUKA | $39.2K | 2 |
| PHARM DRUG&MED:MONTELUKAST 10MG 2X14TACCORD-UKEACH FILM COA TAB CONT:MONTELUKAST SODIUM PH.EUR EQ TO MONTELUKAST 10MG | $15.1K | 1 |
| PHARMA DRUG MED MONTELUKAST CHEW 5MG 2X14T ACCORD UK MT Each uncoa tab cont Montelukast Sodium eq to Montelukast 5mg | $11.1K | 1 |
ACCORD UK imports 13 distinct Montelukast formulations from India. The top formulation is PHARMA DRUGS & MEDI MONTELUKAST 10MG 2X1 with 9 shipments worth $353.6K.
Regulatory Requirements: Importing Montelukast into United Kingdom
What ACCORD UK and other importers must comply with to import Montelukast from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Montelukast
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Montelukast from India and How Much Does ACCORD UK Import?
India exported $30.6M worth of Montelukast through 6,431 shipments from 510 suppliers to 138 countries, serving 1,324 buyers globally. ACCORD UK imports $1.1M of this total, accounting for 0.8% of India's Montelukast exports with 45 shipments from UNITED KINGDOM. This is verified from 45 customs shipment records covering 13 distinct formulations.
What Is the Average Order Value for ACCORD UK's Montelukast Imports?
ACCORD UK's average Montelukast order value is $24.5K per consignment, based on 45 shipments totaling $1.1M. ACCORD UK is based in UNITED KINGDOM and ranks #14 among all Montelukast importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Montelukast to ACCORD UK?
ACCORD UK sources Montelukast from 1 verified Indian supplier: INTAS PHARMACEUTICALS LIMITED ($1.1M, 100.0%). This is based on 45 customs records.
How Does ACCORD UK Compare to Other Montelukast Importers?
ACCORD UK ranks #14 among 1,324 Montelukast importers from India with a 0.8% market share. The top 3 importers are UNICHEM PHARMACEUTICALS (USA) INC. ($5.6M), BREATHEFREE LANKA PVT LTD ($3.4M), UNICHEM PHARMACEUTICALS USA INC ($2.6M). ACCORD UK processed 45 shipments from UNITED KINGDOM.
About ACCORD UK
ACCORD UK imports 11 products worth $7.7M. Beyond Montelukast, top products include Apixaban, Letrozole, Irinotecan, Pioglitazone, Cytarabine. View the complete ACCORD UK profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Montelukast — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Montelukast shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ACCORD UK matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ACCORD UK's capped import value divided by total capped export value for Montelukast across all Indian exporters.
- 5.Verified Records: This page is backed by 45 individual customs records matching ACCORD UK importing Montelukast, covering 13 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 138+ countries, 1,324+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Montelukast Import Data for ACCORD UK
Access order-level details, pricing data, supplier connections, and competitive analysis for ACCORD UK's Montelukast imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ACCORD UK
Full Company Profile →
11 products · $7.7M total trade · 5 categories
ACCORD UK × Montelukast
Verified from customs records
Company Overview
Top Products by ACCORD UK
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ACCORD UK.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Montelukast. For current order-level data, contact TransData Nexus.